Dr. Juan Granada, Executive Director and Chief Innovation Officer of the CRF Skirball Center for Innovation, was interviewed by Diagnostic and Interventional Cardiology at TVT 2015. Dr. Granada discussed the evolution of TAVR technology including the importance of imaging and the heart team, differences in clinical practice within and outside of the U.S., as well as the potential of emerging TAVR devices.

In honor of American Heart Month, CRF participated in Mediaplanet’s Cardiovascular Health campaign, joining other healthcare leaders to raise awareness about the dangers of heart disease and the risks our nation faces today. Dr. Lewin’s column discusses some of the latest advances in the treatment of heart disease, such as transcatheter aortic valve disease (TAVR) and bioresorbable stents, as well the role of health reform and lifestyle choices. The campaign was distributed through USA Today on February 20, 2015 and is published online. Visit the site to learn more about protecting your heart: http://www.hearthealthawareness.com/.

CRF founder, Dr. Martin Leon was featured in a New York Times article on transcatheter aortic valve replacement. The piece discusses the history of the procedure, its current use in the oldest and sickest patients, as well as its potential in lower-risk patients. The article is part of  "Mending Hearts," a series exploring new approaches to treating heart disease.